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Neonatal testicular tumors are rare and should be considered in the differential diagnosis of newborn scrotal
masses. Juvenile granulosa cell tumor (JGCT) accounts for about 5% of all prepubertal testis tumors. As a benign
neoplasm, radical orchiectomy is sufficient for treatment. We report a case of a newborn with a prenatal diagnosis
of scrotal mass. After surgery, the histological diagnosis was juvenile granulosa cell tumor. To date the patient is
healthy.
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Prepubertal testicular tumors are rare and they account
for 1% of all pediatric solid tumors. Granulosa cell
tumor is a benign neoplasm, and it can be distinguished
by adult or juvenile type, with the juvenile type account-
ing for 1% to 5% of all prepubertal testis tumors. Al-
though rare, it is the most common stromal cord
neoplasm of the testis in infancy [1]. JGCT typically
presents a painless scrotal mass. Ultrasound evaluation
typically shows a circumscribed tumor with multicystic
appearance [2]. Only one case of prenatal diagnosis has
been reported [3]. Although inguinal orchiectomy has
been the standard surgical therapy, a testicular sparing
surgery has been recently proposed but it is still not
general practice among pediatric surgeons. We reported
a case of JGCT with prenatal diagnosis treated by an
orchiectomy performed with a prescrotal approach.Case report
A full term baby was born by natural delivery with a
normal APGAR score and a birth weight of 3200 grams.
Fetal ultrasound at 36th week of gestation showed a mul-
ticystic testicular mass on the left side. Postnatal ultra-
sound revealed increased size of the testicle (1.57 × 1.33
cm) due to a well encapsulated, complex cystic mass and* Correspondence: rossellaangotti@libero.it
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reproduction in any medium, provided the ora Doppler scan showed increased blood flow. The con-
trolateral gonad was normal and showed homogeneous
echotexture. After the birth, the baby was admitted to
our department for the management of a "left scrotal
mass". Family history included two cases of Down's
syndrome and no other urogenital problems. The baby
was in good health and without clinical evidence of
dysmorphic features or ambiguous genitalia. The right
testicle had descended, hypoplastic and the penis was
normal. The left testicle was in situ and painless, with
increased size and consistency. Bilateral inguinal hernia
and palpable lymphadenopathy were absent. We per-
formed ultrasonography of the abdomen and testis, as
well as karyotype, blood chemistry and hormone profile.
The abdominal ultrasound, blood chemistry and karyo-
type were normal. Testicular scans confirmed the pres-
ence of a cystic mass in the left gonad (Figure 1).
Abnormal serum tumor markers were: alphafetoprotein
(AFP) 6679 IU/ml, human chorionic gonadotropin 8
mIU/ml, testosterone 1.75 ng/ml and inhibin B 346 pg/
ml. After long discussion with the parents, it was
decided to perform left radical orchiectomy by sub-
inguinal (prescrotal) skin incision (Figure 2). Macro-
scopic features of the testis suggested a neoplastic
mass (Figure 3). The gonad had increased size with a
pearly white surface and apparently complete capsule.
No torsion of the tumor was found. Histological exam-
ination showed a juvenile granulosa cell tumor withLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Ultrasound image obtained at birth revealing
enlarged left testicle (1.57 × 1.33 cm) and a well encapsulated,
complex cystic mass.
Figure 3 Macroscopic features of the testicle after surgery.
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calretinin and negative for AFP. When incised, the
gonad was spongy and yellow with many microcysts and
no normal testicular parenchyma. There were no intra
or postoperative complications. The baby was discharged
three days later. Testicular and abdominal ultrasonog-
raphy a month after surgery showed an empty left scro-
tum and an absence of pathological masses in the
abdomen. Today the patient is healthy without any pro-
blems. It is planned to check the patient every year for
at least 5 years. The parents were informed of the prog-
nosis and the ongoing clinical examinations and tests
required.Figure 2 Prescrotal skin incision.Discussion
The granulosa cell tumor (GCT) is a distinctive form of
gonadal sex cord stromal tumor and accounts for 1-5%
of all prepubertal testis tumors. It is a benign neoplasm,
hormonally inactive and its prognosis is very good.
Although usually diagnosed in the first year of life with
a typical clinical presentation characterized by a painless
testicular mass that may involve an undescended or
scrotal testis, some authors reported a prenatal diagnose
of testicular mass. Peterson and Skoog reported a case
of a cystic structure seen with an ultrasound evaluation
at 35 week’s gestation [3]. In our case fetal ultrasound at
36th week of gestation showed a multicystic alteration of
the left testicle. As confirmed by our case, prenatal diag-
nosis is difficult but possible. Evidence of a general tes-
ticular alteration in the unborn baby enabled early
diagnosis at birth by clinical examination. Sometimes the
tumor presents concomitantly with neonatal torsion [2,4].
Our patient was a neonate and the testis involved was
in situ, without torsion. As the tumor may be associated
with anomalous karyotype or ambiguous genitalia [5,6]
we performed a genetic test, which revealed a normal
karyotype, and the clinical features of the genitalia
were normal.
Postnatal management consisted of abdominal and
testicular ultrasound, karyotyping, blood chemistry and
hormonal evaluation. Abdominal ultrasound was nega-
tive, whereas testicular scans showed a left testicle of
increased size and echotexture.
In our practice we use to determine serum AFP and
B-HCG in all infants with a testicular tumors. In our
case serum levels of AFP and B-HCG were elevated at
preoperative evaluation, according to the reference range
for normal AFP established by WU et al. [7], as many
Authors recognize the normal serum AFP range for neo-
nates varies according to gestational age and body
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[8]. Serum AFP in the normal range for age reliably
excludes a yolk sac tumor and for this reasons some
authors reported that this fact indicates that a testis
sparing procedure is feasible [9]. As stated by Grady
et al., normal AFP level should not be expected in
infants with benign teratoma [10].
In our case we decided to perform a total orchiectomy
because of the presence of elevated values of serum AFP.
We performed a subinguinal approach with the possibility
to realize a safe orchiectomy with an high clamping of
spermatic vessels. This approach is less invasive as an
inguinal approach and it allows to perform a safe orchiec-
tomy. This incision enables a good visualization of the
testicle and spermatic cord, allowing complete excision of
the intact mass and thorough assessment of the margins
for partial resection if possible.
Chemotherapy and radiotherapy are not contemplated
for this tumor because it is non invasive and metastases
have never been described.
Follow-up is a controversial topic; some authors
suggest that it should be performed for at least 5 years
after surgery, as for most other tumors. Others argue
that because orchiectomy is the only treatment, no
further management is required after surgical removal
of the testicle [5]. However, we decided to evaluate the
patient one and three months after the surgery, with
blood tests and testicular ultrasound. We suggested
annual ultrasonography and clinical evaluation for at
least 5 years after surgery.
Conclusion
We agree with other reports that although neonatal
testicular tumors are rare, they should be considered in
the differential diagnosis of scrotal masses in newborns.
Testicular masses should be considered pathological until
proven otherwise and a prenatal diagnosis of a scrotal
mass is possible. We therefore recommend thorough
inspection of the genitalia at birth, followed if necessary
by hormonal assessment and testicular ultrasound. In
patients affected by a testicular neoplastic disease, we
argue that the only possible approach is inguinal. A sub-
inguinal approach enables the testicle and spermatic cord
to be exposed, allowing complete excision of the intact
mass and thorough assessment of the margins for partial
resection if possible. Follow-up of the present case is still
too short to exclude recurrence, although no cases of
recurrence have been reported in literature. In conclu-
sion, the main aim of our follow-up of this patient will be
to avoid damage to the surviving testicle, protect fertility
and monitor for eventual recurrence.
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